DUBLIN–(BUSINESS WIRE)–The “Global Optical Genome Mapping Market By Component (Instruments v/s Consumables), By Application (Genome Assembly, SV Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End User, By Region, Competition Forecast & Opportunities, 2026” report has been added to ResearchAndMarkets.com’s offering.
The global optical genome mapping market is projected to accomplish exemplary growth in the forecast period, 2022-2026 with an impressive CAGR. The market growth can be attributed to the increasing advancements in medicine to find effective and efficient treatments for various evolving chronic diseases.
The optical genome mapping method is highly accurate procedure and is quite affordable; these advantages are sufficiently supporting the growth of the global optical genome mapping market in the next five years. Moreover, increasing biotechnological studies and research is supporting the growth of the market. Enhanced microbiological methods for new drug development and treatment procedure is one of the major driving factors for the growth of the global optical genome mapping market in the subsequent five years. Small structural variations in the bacterial, protists genome for the drug development procedure is major utilization of the optical genome mapping. Rapidly increasing bio-pharmaceutical advances for the drug manipulation and advancement for the various disease treatment is also aiding the growth of the global optical genome mapping market.
Optical genome mapping is a biotechnical procedure of constructing ordered, genome-wide, high-resolution restriction maps from single, stained molecules of DNA, called optical maps. The complete procedure involves a complex process of DNA barcoding, template nicking, gap formation, fluorochrome incorporation, imaging, and photo bleaching along with repeated cycle of fluorochrome incorporation and photo bleaching. The process is less time consuming and is less costly as compared to similar usability biotechnological processes.
The global optical genome mapping market segmentation is based on component, application, end user, competitional landscape, and regional distribution. Based on component, the market is further divided between instruments and consumables. Optical genome mapping plays major part in drug development procedures thus, consumable component can be expected to hold the largest revenue shares of the market segment and assert its dominance over the segment in the upcoming five years. Diagnostic prenatal testing for the detection and prevention of genetic disorders optical genome mapping is a novel method is able to detect all classes of structural variations (SVs), including copy number variations (CNVs) and thus provide better testing instruments and testing kits. The market is expected to support significant growth in the upcoming five years.
Holding the major shares of the global optical genome mapping market are OpGen, Inc., Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Genomique, among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through optical genome mapping. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Objective of the Study:
- To analyze the historical growth of the market size of global optical genome mapping market from 2016 to 2019.
- To estimate and forecast the market size of global optical genome mapping market from 2020 to 2026 and growth rate until 2026.
- To classify and forecast global optical genome mapping market based on component, application, end user, competitional landscape, and regional distribution.
- To identify dominant region or segment in the global optical genome mapping market.
- To identify drivers and challenges for global optical genome mapping market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global optical genome mapping market.
- To identify and analyze the profile of leading players operating in global optical genome mapping market.
- To identify key sustainable strategies adopted by market players in global optical genome mapping market.
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Optical Genome Mapping Market
4. Executive Summary
5. Voice of Customer
6. Global Optical Genome Mapping Market Outlook
7. North America Optical Genome Mapping Market Outlook
8. Europe Optical Genome Mapping Market Outlook
9. Asia-Pacific Optical Genome Mapping Market Outlook
10. South America Optical Genome Mapping Market Outlook
11. Middle East and Africa Optical Genome Mapping Market Outlook
12. Market Dynamics
13. Market Trends & Developments
14. Competitive Landscape
- OpGen, Inc.
- Bionano Genomics, Inc.
- Nabsys Inc
- Nucleome Informatics Pvt Ltd
- France Genomique
For more information about this report visit https://www.researchandmarkets.com/r/itl30l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900